AI chatbot for prostate radiation education
Part of Cancer clinical trials.
This trial tests an AI chatbot designed to help educate patients about prostate cancer radiation therapy. It may provide a simple way to answer your questions before treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with prostate cancer
- You are scheduled to receive radiation therapy for prostate cancer at Brigham and Women's Hospital
- You can speak English
- You are able to understand and agree to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if an AI tool can improve the safety review of radiation treatment plans for prostate cancer. Patients continue their normal treatment while the AI helps doctors check the plans.
This trial tests whether an AI chatbot can help women with breast cancer by providing information and support. You may join regardless of your cancer stage if you can use the chatbot in Arabic.
This trial tests if an AI tool can help you better understand your prostate cancer diagnosis results. If you recently had a prostate biopsy at Cleveland Clinic but haven't discussed the results yet, this study may help you get clear information.
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
This trial tests whether an AI-powered chatbot can help people with cancer feel better emotionally and improve their quality of life. You can join if you are currently in cancer treatment, feeling distressed, and have a smartphone.
This trial tests a chatbot that gives support and advice to young adults who have finished cancer treatment. It aims to help you manage symptoms and side effects through an easy-to-use online tool.
Hear when a new Prostate Cancer Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.